PF-02545920
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for PF-02545920, covering 2011-11-16 to 2018-08-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia [Phase 1]